You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bone marrow transplant

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Fibrosis, Emphysema or COPD Trial in Pittsburgh (CD3/CD19 negative hematopoietic stem cells, Rituximab,

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Emphysema or COPD
  • CD3/CD19 negative hematopoietic stem cells
  • +6 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Hematopoietic Stem Cell Transplant, Hematologic Diseases, Physical Activity Trial in Hershey (Exercise, Prehabilitation

Recruiting
  • Hematopoietic Stem Cell Transplant
  • +3 more
  • Exercise
  • Prehabilitation Education
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Mar 18, 2022

Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

Recruiting
  • Primary Immune Deficiency Disorder
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 20, 2022

Primary Immunodeficiency, PID Trial in Pittsburgh (CD3/CD19 neg allogeneic BMT)

Active, not recruiting
  • Primary Immunodeficiency
  • PID
  • CD3/CD19 neg allogeneic BMT
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of University of Pittsburgh Me
Oct 6, 2021

Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

Withdrawn
  • Hodgkin Lymphoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Nov 28, 2022

Leukemia, MDS Trial (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Feb 17, 2022

Ponatinib in CML Patients in Chronic Phase

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Therapeutic drug monitoring
  • Molecular Response
  • Cagliari, Italy
  • +4 more
Nov 3, 2023

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Dec 13, 2022

Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow

Available
  • Benign Neoplasm
  • +3 more
  • Bone Marrow Transplantation
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 9, 2021

Vaginal Microbiome and Development of Vulvovaginal Graft Versus

Recruiting
  • Bone Marrow Transplant Complications
  • No intervention
  • Jerusalem, Israel
    Hadassah Medical Center
Mar 30, 2022

Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)

Completed
  • Severe Aplastic Anemia
  • Bone Marrow Failure Syndromes
  • Bone marrow transplant
  • +7 more
  • Baltimore, Maryland
  • +1 more
Feb 10, 2022

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +6 more
  • (no location specified)
Dec 8, 2021

Severe Combined Immunodeficiency (SCID), Immunodeficiency With Predominant T-cell Defect, Unspecified, Severe Chronic

Enrolling by invitation
  • Severe Combined Immunodeficiency (SCID)
  • +8 more
  • CD3/CD19 negative allogeneic hematopoietic stem cells
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
Dec 6, 2021

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Baltimore (Bone Marrow Transplantation, Sorafenib, Sorafenib Tosylate)

Completed
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Bone Marrow Transplantation
  • +2 more
  • Baltimore, Maryland
  • +1 more
May 27, 2021

Ph+ ALL, Bone Marrow Transplant, Minimal Residual Disease Trial in Tianjin (the usage of Olverembatinib combined with Inotuzumab

Not yet recruiting
  • Ph+ ALL
  • +2 more
  • the usage of Olverembatinib combined with Inotuzumab Ozogamicin
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Oct 30, 2022

Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA

Recruiting
  • Sickle Cell Anemia
  • +2 more
  • CD3/CD19 depleted leukocytes
  • +6 more
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
May 4, 2022

Opportunistic Fungal Infection, Opportunistic Viral Infection, Bone Marrow Transplant Infection Trial in Patra, Thessaloníki

Recruiting
  • Opportunistic Fungal Infection
  • +2 more
  • Pentavalent-specific T cells (penta-STs)
  • Patra, Greece
  • +1 more
Jul 26, 2022

HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against

Not yet recruiting
  • HPV 16+ Recurrent or Metastatic Cancer
  • CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
  • Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
  • (no location specified)
Jun 27, 2022

Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United

Recruiting
  • Bone Marrow Failure Syndrome
  • +6 more
  • Los Angeles, California
  • +23 more
Aug 15, 2022

Nutrition and Metabolic Prehabilitation in HSCT Patients UK and

Completed
  • Haematological Malignancy
  • +6 more
  • Non validated Survey
  • Nottingham, Nottinghamshire, United Kingdom
    Nottingham University Hospitals NHS Trust
Apr 22, 2022

Test: A Performance Study With Primary Immunodeficiency Tunisia

Not yet recruiting
  • Primary Immunodeficiency Diseases
  • IgG deficiency rapid screening test
  • Tunis, Tunisia
    National Bone Marrow Transplant center
Nov 10, 2022

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Antibody-mediated Rejection, Allosensitization Trial in New York (Isatuximab, bone marrow biopsy)

Not yet recruiting
  • Antibody-mediated Rejection
  • Allosensitization
  • New York, New York
    NYU Langone Health
May 16, 2023

Bone Marrow Transplant Complications, Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial in Kansas City (Ultrasound

Active, not recruiting
  • Bone Marrow Transplant Complications
  • +3 more
  • Ultrasound Examination
  • Kansas City, Missouri
    Children's Mercy Hospital
Jun 3, 2022

Next Generation Sequencing in Familial Acute Myeloid Leukemia

Recruiting
  • Leukemia
  • Analysis with molecular biology
  • Brescia, Italy
    Chair of Hematology and Bone marrow Transplant Unit
Apr 21, 2022